NewsRx

Search our medical news database

Hemophilia

Supplement filed for approval of needless device used with Kogenate FS

Published in Medical Letter on the CDC and FDA, December 7th, 2003

Bayer Biological Products (BP) announced the filing of a pre-approval supplement for Bio-Set, a new needleless device for the reconstitution and use of Kogenate FS (Antihemophilic Factor [Recombinant], Formulated with Sucrose) for the treatment of hemophilia A.

The supplement was filed with the United States Food and Drug Administration and will be followed by filings with regulatory authorities in other countries. Upon approval, Kogenate FS with Bio-Set will be the first and only self-contained device that provides a prefilled syringe for rapid and safe reconstitution and infusion without exposed needles. Bio-Set will be available exclusively with Kogenate FS and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook